Patent · US Active

Compositions and methods for treating ocular diseases

US12329853B2 · kind B2 · utility

0Cited by
106References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2022
Grant dateJun 17, 2025
Priority date
Expiry dateOct 31, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08L2312/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the treatment of ocular diseases in a human subject. In particular, the invention relates to an intracameral administration of a sustained release biodegradable intracameral implant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.